CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- 4 Open-market sale Chief Legal Officer sold 50,000 shares at an average $13.41 ($670,264)
- 4 Open-market sale Chief Operating Officer sold 53,997 shares at an average $13.18 ($711,817)
- 4/A Shares withheld for taxes Chief Operating Officer gave up 8,424 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief Legal Officer gave up 8,880 shares (to pay taxes)
- 4 Grant or award Chief Operating Officer acquired 69,686 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 69,686 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 69,686 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 59,170 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 23,977 shares (to pay taxes)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Financial Officer gave up 6,515 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 17,829 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Commercial Officer gave up 5,689 shares (to pay taxes)
Page 3 of 26 · 513 filings